β-catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells

Science Translational Medicine

Volumn 6, Issue 225, 2014, Pages

  Keerthivasan, Shilpa ^a   Aghajani, Katayoun ^a,b   Dose, Marei ^a   Molinero, Luciana ^a   Khan, Mohammad W ^c,d   Venkateswaran, Vysak ^c   Weber, Christopher ^e   Emmanuel, Akinola Olumide ^a   Sun, Tianjao ^a   Bentrem, David J ^c,f   Mulcahy, Mary ^c   Keshavarzian, Ali ^g   Ramos, Elena M ^c   Blatner, Nichole ^c   Khazaie, Khashayarsha ^c,h   Gounari, Fotini ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f JESSE BROWN VA MEDICAL CENTER   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RELATED ORPHAN RECEPTOR GAMMA T; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; COLITIS; COLON CANCER; CONTROLLED STUDY; GENETICALLY ENGINEERED MOUSE STRAIN; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LYMPHOCYTE FUNCTION; MOLECULAR IMPRINTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH17 CELL; TUMOR PROMOTION; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLITIS; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T CELL TRANSCRIPTION FACTOR 1; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; WNT SIGNALING PATHWAY;

EID: 84896347048     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007607     Document Type: Article

References (50)

1. D. R. Littman, A. Y. Rudensky, Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
2. C. Asseman, S. Mauze, M. W. Leach, R. L. Coffman, F. Powrie, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
3. + T cells in an interleukin-10-dependent manner. Immunity 34, 554-565 (2011).
4. A. Chaudhry, R. M. Samstein, P. Treuting, Y. Liang, M. C. Pils, J. M. Heinrich, R. S. Jack, F. T. Wunderlich, J. C. Brüning, W. Müller, A. Y. Rudensky, Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578 (2011).
5. Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson Jr., W. Muller, A. Y. Rudensky, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
6. T. Korn, E. Bettelli, M. Oukka, V. K. Kuchroo, IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
7. J. Van Limbergen, D. C. Wilson, J. Satsangi, The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 10, 89-116 (2009).
8. M. W. Khan, A. Keshavarzian, E. Gounaris, J. E. Melson, E. C. Cheon, N. R. Blatner, Z. E. Chen, F. N. Tsai, G. Lee, H. Ryu, T. A. Barrett, D. J. Bentrem, P. Beckhove, K. Khazaie, PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin. Cancer Res. 19, 2342-2354 (2013).
9. J. Terzic, S. Grivennikov, E. Karin, M. Karin, Inflammation and colon cancer. Gastroenterology 138, 2101-2114.e2105 (2010).
10. K. Khazaie, N. R. Blatner, M. W. Khan, F. Gounari, E. Gounaris, K. Dennis, A. Bonertz, F. N. Tsai, M. J. Strouch, E. Cheon, J. D. Phillips, P. Beckhove, D. J. Bentrem, The significant role of mast cells in cancer. Cancer Metastasis Rev. 30, 45-60 (2011).
11. N. R. Blatner, A. Bonertz, P. Beckhove, E. C. Cheon, S. B. Krantz, M. Strouch, J. Weitz, M. Koch, A. L. Halverson, D. J. Bentrem, K. Khazaie, In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc. Natl. Acad. Sci. U.S.A. 107, 6430-6435 (2010).
12. N. R. Blatner, M. F. Mulcahy, K. L. Dennis, D. Scholtens, D. J. Bentrem, J. D. Phillips, S. Ham, B. P. Sandall, M. W. Khan, D. M. Mahvi, A. L. Halverson, S. J. Stryker, A. M. Boller, A. Singal, R. K. Sneed, B. Sarraj, M. J. Ansari, M. Oft, Y. Iwakura, L. Zhou, A. Bonertz, P. Beckhove, F. Gounari, K. Khazaie, Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4, 164ra159 (2012).
13. M. Tosolini, A. Kirilovsky, B. Mlecnik, T. Fredriksen, S. Mauger, G. Bindea, A. Berger, P. Bruneval, W. H. Fridman, F. Pagès, J. Galon, Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 71, 1263-1271 (2011).
14. + T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27, 186-192 (2009).
15. +) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J. Immunother. 33, 435-441 (2010).
16. +) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 137, 1270-1279 (2009).
17. reg cells in cancer: A case of multiple personality disorder. Sci. Transl. Med. 4, 164fs44 (2012).
18. E. Gounaris, N. R. Blatner, K. Dennis, F. Magnusson, M. F. Gurish, T. B. Strom, P. Beckhove, F. Gounari, K. Khazaie, T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res. 69, 5490-5497 (2009).
19. reg within tumorigenic tentacles. Cancer Res. 69, 5619-5622 (2009).
20. K. W. Kinzler, B. Vogelstein, Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
21. N. Harada, Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, M. M. Taketo, Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J. 18, 5931-5942 (1999).
22. E. Gounaris, S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, V. P. Rao, T. Poutahidis, R. Weissleder, K. M. McNagny, K. Khazaie, Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. U.S.A. 104, 19977-19982 (2007).
23. K. L. Dennis, Y. Wang, N. R. Blatner, S. Wang, A. Saadalla, E. Trudeau, A. Roers, C. T. Weaver, J. J. Lee, J. A. Gilbert, E. B. Chang, K. Khazaie, Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res. 73, 5905-5913 (2013).
24. K. Germar, M. Dose, T. Konstantinou, J. Zhang, H. Wang, C. Lobry, K. L. Arnett, S. C. Blacklow, I. Aifantis, J. C. Aster, F. Gounari, T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 20060-20065 (2011).
25. D. Kovalovsky, Y. Yu, M. Dose, A. Emmanouilidou, T. Konstantinou, K. Germar, K. Aghajani, Z. Guo, M. Mandal, F. Gounari, β-Catenin/Tcf determines the outcome of thymic selection in response to abTCR signaling. J. Immunol. 183, 3873-3884 (2009).
26. Z. Guo, M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, F. Gounari, β-Catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 109, 5463-5472 (2007).
27. Q. Yu, J. M. Sen, β-Catenin regulates positive selection of thymocytes but not lineage commitment. J. Immunol. 178, 5028-5034 (2007).
28. Y. Xu, D. Banerjee, J. Huelsken, W. Birchmeier, J. M. Sen, Deletion of β-catenin impairs T cell development. Nat. Immunol. 4, 1177-1182 (2003).
29. F. Gounari, I. Aifantis, K. Khazaie, S. Hoeflinger, N. Harada, M. M. Taketo, H. von Boehmer, Somatic activation of β-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat. Immunol. 2, 863 -869 (2001).
30. R. Wang, H. Xie, Z. Huang, J. Ma, X. Fang, Y. Ding, Z. Sun, T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. J. Immunol. 187, 5964-5973 (2011).
31. Y. Ding, S. Shen, A. C. Lino, M. A. Curotto de Lafaille, J. J. Lafaille, Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat. Med. 14, 162-169 (2008).
32. J. van Loosdregt, V. Fleskens, M. M. Tiemessen, M. Mokry, R. van Boxtel, J. Meerding, C. E. Pals, D. Kurek, M. R. Baert, E. M. Delemarre, A. Gröne, M. J. Koerkamp, A. J. Sijts, E. E. Nieuwenhuis, M. M. Maurice, J. H. van Es, D. Ten Berge, F. C. Holstege, F. J. Staal, D. M. Zaiss, B. J. Prakken, P. J. Coffer, Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity 39, 298-310 (2013).
33. P. Muranski, Z. A. Borman, S. P. Kerkar, C. A. Klebanoff, Y. Ji, L. Sanchez-Perez, M. Sukumar, R. N. Reger, Z. Yu, S. J. Kern, R. Roychoudhuri, G. A. Ferreyra, W. Shen, S. K. Durum, L. Feigenbaum, D. C. Palmer, P. A. Antony, C. C. Chan, A. Laurence, R. L. Danner, L. Gattinoni, N. P. Restifo, Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35, 972-985 (2011).
34. Q. Yu, A. Sharma, A. Ghosh, J. M. Sen, T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J. Immunol. 186, 3946 -3952 (2011).
35. J. Ma, R. Wang, X. Fang, Y. Ding, Z. Sun, Critical role of TCF-1 in repression of the IL-17 gene. PLOS One 6, e24768 (2011).
36. E. Gounaris, C. H. Tung, C. Restaino, R. Maehr, R. Kohler, J. A. Joyce, H. L. Ploegh, T. A. Barrett, R. Weissleder, K. Khazaie, Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLOS One 3, e2916 (2008).
37. K. Khazaie, M. Zadeh, M. W. Khan, P. Bere, F. Gounari, K. Dennis, N. R. Blatner, J. L. Owen, T. R. Klaenhammer, M. Mohamadzadeh, Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. U.S.A. 109, 10462-10467 (2012).
38. F. Gounari, R. Chang, J. Cowan, Z. Guo, M. Dose, E. Gounaris, K. Khazaie, Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat. Immunol. 6, 800-809 (2005).
39. J. R. Saam, J. I. Gordon, Inducible gene knockouts in the small intestinal and colonic epithelium. J. Biol. Chem. 274, 38071-38082 (1999).
40. A. N. Burnett-Hartman, P. A. Newcomb, J. D. Potter, M. N. Passarelli, A. I. Phipps, M. A. Wurscher, W. M. Grady, L. C. Zhu, M. P. Upton, K. W. Makar, Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 73, 2863-2872 (2013).
41. A. Giatromanolaki, M. I. Koukourakis, A. V. Koutsopoulos, A. L. Harris, K. C. Gatter, E. Sivridis, Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis. 15, e223-e230 (2013).
42. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
43. C. Mosimann, G. Hausmann, K. Basler, β-Catenin hits chromatin: Regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 10, 276-286 (2009).
44. G. Eberl, S. Marmon, M. J. Sunshine, P. D. Rennert, Y. Choi, D. R. Littman, An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73 (2004).
45. M. Ciofani, A. Madar, C. Galan, M. Sellars, K. Mace, F. Pauli, A. Agarwal, W. Huang, C. N. Parkurst, M. Muratet, K. M. Newberry, S. Meadows, A. Greenfield, Y. Yang, P. Jain, F. K. Kirigin, C. Birchmeier, E. F. Wagner, K. M. Murphy, R. M. Myers, R. Bonneau, D. R. Littman, A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
46. M. Dose, A. O. Emmanuel, J. Chaumeil, J. Zhang, T. Sun, K. Germar, K. Aghajani, E. M. Davis, S. Keerthivasan, A. L. Bredemeyer, B. P. Sleckman, S. T. Rosen, J. A. Skok, M. M. Le Beau, K. Georgopoulos, F. Gounari, β-Catenin induces T-cell transformation by promoting genomic instability. Proc. Natl. Acad. Sci. U.S.A. 111, 391-396 (2014).
47. D. S. Parker, Y. Y. Ni, J. L. Chang, J. Li, K. M. Cadigan, Wingless signaling induces widespread chromatin remodeling of target loci. Mol. Cell. Biol. 28, 1815-1828 (2008).
48. R. M. Samstein, A. Arvey, S. Z. Josefowicz, X. Peng, A. Reynolds, R. Sandstrom, S. Neph, P. Sabo, J. M. Kim, W. Liao, M. O. Li, C. Leslie, J. A. Stamatoyannopoulos, A. Y. Rudensky, Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153-166 (2012).
49. K. Otero, I. R. Turnbull, P. L. Poliani, W. Vermi, E. Cerutti, T. Aoshi, I. Tassi, T. Takai, S. L. Stanley, M. Miller, A. S. Shaw, M. Colonna, Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin. Nat. Immunol. 10, 734-743 (2009).
50. L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjöblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K. Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, V. E. Velculescu, B. Vogelstein, The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).